Correlation Between Virax Biolabs and Cellectar Biosciences
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Cellectar Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Cellectar Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Cellectar Biosciences, you can compare the effects of market volatilities on Virax Biolabs and Cellectar Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Cellectar Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Cellectar Biosciences.
Diversification Opportunities for Virax Biolabs and Cellectar Biosciences
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Virax and Cellectar is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Cellectar Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectar Biosciences and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Cellectar Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectar Biosciences has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Cellectar Biosciences go up and down completely randomly.
Pair Corralation between Virax Biolabs and Cellectar Biosciences
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 2.52 times more return on investment than Cellectar Biosciences. However, Virax Biolabs is 2.52 times more volatile than Cellectar Biosciences. It trades about 0.03 of its potential returns per unit of risk. Cellectar Biosciences is currently generating about 0.0 per unit of risk. If you would invest 409.00 in Virax Biolabs Group on September 12, 2024 and sell it today you would lose (228.00) from holding Virax Biolabs Group or give up 55.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Cellectar Biosciences
Performance |
| Timeline |
| Virax Biolabs Group |
| Cellectar Biosciences |
Virax Biolabs and Cellectar Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Cellectar Biosciences
The main advantage of trading using opposite Virax Biolabs and Cellectar Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Cellectar Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectar Biosciences will offset losses from the drop in Cellectar Biosciences' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Cellectar Biosciences vs. Monopar Therapeutics | Cellectar Biosciences vs. Pulmatrix | Cellectar Biosciences vs. Tenax Therapeutics | Cellectar Biosciences vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |